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Received January 27, 2012; accepted May 2, 2012AbstractBackground: Adrenal insufficiency (AI) is an uncommon but life-threatening disorder if it progresses to adrenal crisis. The nationwide trend of
AI epidemiology in Taiwan has been infrequently reported.
Methods: Based on complete hospitalization datasets from the National Health Insurance Research Database, the trend of the annual incidence of
AI from 1996 to 2008 in Taiwan was retrospectively analyzed. Special attention was paid to age-specific incidence, contributing factors as well
as comorbidity at the time of AI diagnosis.
Results: Of the existing 35,884,231 hospitalization records, there were 52,660 with AI diagnosis in 32,085 patients (15,914 women and 16,163
men). The annual incidence of AI increased over time from 6.4/105 (n ¼ 1280) in 1996 to 15.2/105 (n ¼ 3494) in 2008. Nearly four-fifths (77%,
n ¼ 24,688) of the patients were aged at least 60 years at the time of their first AI diagnosis. The increase of the annual incidence of AI during
the study period was largely attributed to disease prevalence in patients aged 60 years and over, with the most marked increase in the population
aged 80 years of age from 51.1/105 in 1996 to 179.9/105 in 2008. Most patients with newly diagnosed AI were treated at internal medicine wards
(81.1%, n ¼ 26,032), at academic medical centers (51.9%, n ¼ 16,648) and in southern Taiwan (54%, n ¼ 17,334). The most common
comorbidity was pneumonia (6.4%, n ¼ 2051), followed by urinary tract infection (6.4%, n ¼ 2049), diabetes mellitus (6.2%, n ¼ 1985),
electrolyte imbalance (4.8%, n ¼ 1551), and chronic obstructive pulmonary disease (4.5%, n ¼ 1428).
Conclusion: The annual incidence of AI in Taiwan had continuously increased in recent years, and elderly patients accounted for the majority of
the increase. In the face of an increasingly aging population, Taiwanese physicians should pay more attention to this easily overlooked disease.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Adrenal insufficiency (AI) is uncommon but life-
threatening if it progresses to adrenal crisis with electrolyte* Corresponding author. Dr. Tzeng-Ji Chen, Department of Family Medi-
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112, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2012.11.001imbalance, change of consciousness or even shock. The causes
of AI can be primary or secondary. Generally, the number of
patients with secondary AI far exceeds that with primary AI.1
Epidemiological surveys in Caucasian populations revealed
that the prevalence of primary and secondary AI in the 1990s
(9e14/105 and 15e28/105 population respectively) were
higher than those in the 1960s.1,2 The reverse trend was
observed in Japan where incidences of primary AI decreased
from the 1960s to the 1990s.3 In Taiwan, a recent studyhinese Medical Association. All rights reserved.
141Y.-C. Chen et al. / Journal of the Chinese Medical Association 76 (2013) 140e145mentioned that the prevalence of AI among the elderly pop-
ulation has increased continuously since 1996.4 However, the
composition and causes of this increasing trend have not yet
been studied in detail.
The aim of our current study is to analyze the 13-year trend
of annual prevalence and incidence of AI from 1996 to 2008 in
Taiwan by means of the complete nationwide insurance hos-
pitalization claims records. Special attention was paid to age-
specific incidence, contributing factors as well as comorbidity
at AI diagnosis.
2. Methods
The complete datasets of hospitalizations (inpatient
expenditures by admissions) were obtained from the National
Health Insurance (NHI) Research Database at the National
Health Research Institutes in Miaoli, Taiwan.5 A total of
35,884,231 records exist from 1996 to 2008. Each record of
these datasets contains the patient’s identification number,
gender, date of birth, dates of admission and discharge, up to
five discharge diagnoses coded in the International Classi-
fication of Disease, Ninth Revision, Clinical Modification
(ICD-9-CM) format, and the identification number of the
medical care facility. For privacy protection, the original
identification numbers of patients and medical care facilities
were scrambled cryptographically to ensure anonymity.
In the current study, patients with AI were identified ac-
cording to the discharge diagnoses (255.4 in ICD-9-CM). From
the data of all patients with treated AI, their first hospitalizations
with an AI diagnosis during the study period were selected for
incidence estimation and further analysis. Because the NHI
programwas started in 1995 and only electronic claims data after
1996 were available, a consistent definition in calculating the
incidences over the 10 yearswas notwarranted. The incidence of
the first few yearsmight have been underestimated. For each first
hospitalization, the specialty and hospital were extracted. In
calculation, the specialties were classified into officially recog-
nized major specialties. A medical care facility in each hospi-
talization record was linked to the registry file of medical care
facilities (HOSB2008.DAT) to identify its contracted category
and location. The contracted category includes academic medi-
cal center, metropolitan hospital, local community hospital or
primary care clinic. The facility locations were also separated
into groups, which included Taipei, Northern, Central, Southern,
Kao-Ping, or Eastern Branches of the Bureau of NHI.
To analyze the comorbidity of newAIcases, thefirst discharge
diagnosiswas extracted from thehospitalization records inwhich
AI was newly diagnosed. If AI was the primary diagnosis, the
second discharge diagnosis would be extracted instead. The
Clinical Classification Software (CCS) 2010 version6 was used
to classify diagnoses into a manageable number of clinically
meaningful categories with 295 single-level diagnostic groups.2.1. Statistical analysisFig. 1. Annual prevalence and incidence of adrenal insufficiency, 1996e2008.Annual numbers of beneficiaries were obtained from the
official website of the Bureau of NHI5 to serve asdenominators in calculating the annual prevalence and inci-
dence. Age-specific incidence was determined in every age
group in increments of 20 years. From the nonsampled pop-
ulation datasets, descriptive statistics were presented. All
calculations were performed with Perl software version
5.12.1.7
3. Results3.1. PrevalenceFrom 35,884,231 hospitalization records between 1996 and
2008, 52,660 records with AI diagnosis were identified in
32,085 patients (15,914 women and 16,163 men). The annual
prevalence of treated AI gradually increased from 6.4/105
(n ¼ 1280) in 1996 to 20.0/105 (n ¼ 4591) in 2008 (Fig. 1).3.2. Incidence and patients’ characteristicsSimilarly, the annual incidence of AI increased from 6.4/105
(n ¼ 1,280) in 1996 to 15.2/105 (n ¼ 3494) in 2008 (Fig. 1).
The incidences did not differ remarkably between both sexes:
from 6.5/105 in 1996 to 14.8/105 in 2008 in women vs. an
increase from 6.3/105 in 1996 to 15.8/105 in 2008 in men.
Nearly four-fifths (77%, n ¼ 24,688) of the patients aged 60
years and over at the time of their first AI diagnosis (Table 1).
The mean age was 67.3  15.2 years: 67.2  15.0 years in
women and 67.4  15.4 years in men. The increase of annual
incidences during the study period was largely attributed to the
patients aged at least 60 years (Table 1). The increasing trend
was most marked in the population aged 80 years and over:
from 51.1/105 in 1996 to 179.9/105 in 2008 (Fig. 2).3.3. Specialty and hospital in which AI was newly
diagnosedThe records showed that four-fifths of the patients with
newly diagnosed AI were treated at internal medicine wards
1cteristics of the patients at the first diagnosis of adrenal insufficiency, 1996e2008, n (%).
1996 1997 1998 1999 2000 2001 2002 2003 200 05 2006 2007 2008
male 646 (50.5) 696 (50.9) 962 (52.4) 981 (49.7) 1016 (50.8) 1089 (52.5) 1245 (49.8) 1270 (49.0) 145 90 (49.4) 1693 (49.0) 1575 (47.9) 1692 (48.4)
le 634 (49.5) 672 (49.1) 875 (47.6) 990 (50.2) 983 (49.2) 984 (47.4) 1253 (50.1) 1319 (50.9) 154 30 (50.6) 1760 (51.0) 1713 (52.1) 1802 (51.6)
known 0 0 0 1 1 1 2 2 0 0 0 0
roup
19 27 (2.1) 30 (2.2) 32 (1.7) 41 (2.1) 30 (1.5) 24 (1.2) 28 (1.1) 47 (1.8) 3 38 (1.2) 40 (1.2) 37 (1.1) 44 (1.3)
39 61 (4.8) 67 (4.9) 92 (5.0) 97 (4.9) 78 (3.9) 93 (4.5) 93 (3.7) 93 (3.6) 12 16 (3.6) 128 (3.7) 160 (4.9) 130 (3.7)
59 301 (23.5) 298 (21.8) 363 (19.8) 399 (20.2) 354 (17.7) 355 (17.1) 445 (17.8) 437 (16.9) 48 16 (16.0) 543 (15.7) 521 (15.8) 595 (17.0)
e79 775 (60.5) 828 (60.5) 1138 (61.9) 1191 (60.4) 1273 (63.7) 1285 (62.0) 1495 (59.8) 1574 (60.7) 180 60 (57.8) 1964 (56.9) 1760 (53.5) 1778 (50.9)
þ 116 (9.1) 145 (10.6) 212 (11.5) 244 (12.4) 265 (13.3) 317 (15.3) 439 (17.6) 440 (17.0) 56 90 (21.4) 778 (22.5) 810 (24.6) 947 (27.1)
ital type
ademic medical center 632 (49.4) 767 (56.1) 1142 (62.2) 1203 (61.0) 1186 (59.3) 1218 (58.7) 1428 (57.1) 1368 (52.8) 157 61 (48.5) 1637 (47.4) 1428 (43.4) 1503 (43.0)
tropolitan hospital 444 (34.7) 437 (31.9) 501 (27.3) 543 (27.5) 591 (29.6) 614 (29.6) 773 (30.9) 962 (37.1) 115 81 (42.9) 1447 (41.9) 1463 (44.5) 1561 (44.7)
cal hospital 204 (15.9) 164 (12.0) 194 (10.6) 226 (11.5) 223 (11.2) 242 (11.7) 299 (12.0) 261 (10.1) 27 78 (8.6) 369 (10.7) 397 (12.1) 430 (12.3)
ital location
pei 245 (19.1) 267 (19.5) 315 (17.1) 340 (17.2) 349 (17.5) 322 (15.5) 401 (16.0) 377 (14.6) 38 67 (14.5) 669 (19.4) 558 (17.0) 610 (17.5)
rthern 270 (21.1) 285 (20.8) 430 (23.4) 453 (23.0) 399 (20.0) 407 (19.6) 465 (18.6) 507 (19.6) 58 01 (15.6) 582 (16.9) 491 (14.9) 482 (13.8)
ntral 156 (12.2) 190 (13.9) 198 (10.8) 232 (11.8) 190 (9.5) 177 (8.5) 179 (7.2) 203 (7.8) 26 47 (7.7) 280 (8.1) 320 (9.7) 372 (10.6)
uthern 217 (17.0) 173 (12.6) 151 (8.2) 267 (13.5) 320 (16.0) 389 (18.8) 575 (23.0) 740 (28.6) 79 52 (29.6) 906 (26.2) 951 (28.9) 1132 (32.4)
o-Ping 358 (28.0) 414 (30.3) 716 (39.0) 652 (33.1) 706 (35.3) 741 (35.7) 840 (33.6) 727 (28.1) 91 83 (30.5) 949 (27.5) 910 (27.7) 847 (24.2)
stern 34 (2.7) 39 (2.9) 27 (1.5) 28 (1.4) 36 (1.8) 38 (1.8) 40 (1.6) 37 (1.4) 5 70 (2.2) 67 (1.9) 58 (1.8) 51 (1.5)
alty (selected)
ernal medicine 1057 (82.6) 1140 (83.3) 1530 (83.3) 1622 (82.3) 1620 (81.0) 1699 (81.9) 1974 (79.0) 2098 (81.0) 238 84 (80.2) 2820 (81.7) 2661 (80.9) 2845 (81.4)
urology 62 (4.8) 72 (5.3) 75 (4.1) 93 (4.7) 94 (4.7) 80 (3.9) 100 (4.0) 151 (5.8) 14 88 (5.8) 169 (4.9) 158 (4.8) 170 (4.9)
rgery 60 (4.7) 52 (3.8) 94 (5.1) 93 (4.7) 111 (5.6) 100 (4.8) 185 (7.4) 125 (4.8) 19 18 (6.8) 217 (6.3) 185 (5.6) 180 (5.2)
thopedics 48 (3.8) 40 (2.9) 55 (3.0) 64 (3.2) 71 (3.6) 111 (5.4) 145 (5.8) 99 (3.8) 14 99 (3.1) 107 (3.1) 122 (3.7) 99 (2.8)
urosurgery 4 (0.3) 9 (0.7) 11 (0.6) 18 (0.9) 25 (1.3) 23 (1.1) 20 (0.8) 30 (1.2) 3 43 (1.3) 49 (1.4) 72 (2.2) 96 (2.7)
diatrics 19 (1.5) 20 (1.5) 25 (1.4) 36 (1.8) 20 (1.0) 19 (0.9) 18 (0.7) 33 (1.3) 3 30 (0.9) 26 (0.8) 32 (1.0) 31 (0.9)
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
86 (4.4) 77 (3.9) 87 (4.2) 130 (5.2) 159 (6.1) 220 (7.3) 254 (7.9) 267 (7.7) 301 (9.2) 346 (9.9)
110 (5.6) 117 (5.9) 134 (6.5) 144 (5.8) 206 (8.0) 191 (6.3) 218 (6.8) 219 (6.3) 197 (6.0) 267 (7.6)
162 (8.2) 158 (7.9) 145 (7.0) 162 (6.5) 191 (7.4) 144 (4.8) 158 (4.9) 173 (5.0) 145 (4.4) 153 (4.4)
76 (3.9) 81 (4.1) 87 (4.2) 113 (4.5) 130 (5.0) 158 (5.3) 147 (4.6) 216 (6.3) 211 (6.4) 197 (5.6)
86 (4.4) 86 (4.3) 81 (3.9) 142 (5.7) 133 (5.1) 165 (5.5) 153 (4.8) 140 (4.1) 128 (3.9) 142 (4.1)
90 (4.6) 101 (5.1) 92 (4.4) 130 (5.2) 130 (5.0) 120 (4.0) 144 (4.5) 161 (4.7) 129 (3.9) 142 (4.1)
60 (3.0) 45 (2.3) 72 (3.5) 73 (2.9) 81 (3.1) 126 (4.2) 150 (4.7) 187 (5.4) 187 (5.7) 199 (5.7)
103 (5.2) 107 (5.4) 104 (5.0) 106 (4.2) 79 (3.0) 84 (2.8) 84 (2.6) 100 (2.9) 87 (2.6) 73 (2.1)
44 (2.2) 45 (2.3) 47 (2.3) 72 (2.9) 53 (2.0) 84 (2.8) 79 (2.5) 76 (2.2) 70 (2.1) 86 (2.5)
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Comorbidities at the first diagnosis of adrenal insufficiency, 1996e2008, n (
1996 1997 1998
Pneumonia (except that caused
by tuberculosis or sexually
transmitted disease)
21 (1.6) 55 (4.0) 48 (2.6)
Urinary tract infections 59 (4.6) 71 (5.2) 116 (6.3)
Diabetes mellitus with complications 94 (7.3) 100 (7.3) 200 (10.9)
Fluid and electrolyte disorders 45 (3.5) 42 (3.1) 48 (2.6)
Chronic obstructive pulmonary
disease and bronchiectasis
47 (3.7) 54 (3.9) 71 (3.9)
Skin and subcutaneous tissue infections 36 (2.8) 49 (3.6) 81 (4.4)
Septicemia (except in labor) 31 (2.4) 36 (2.6) 55 (3.0)
Other endocrine disorders 135 (10.5) 107 (7.8) 115 (6.3)
Acute cerebrovascular disease 32 (2.5) 27 (2.0) 41 (2.2)(2.6) 35 (1.8) 48 (2.4) 49 (2.4) 47 (1.9) 55 (2.1) 48 (1.6) 66 (2.0) 75 (2.2) 48 (1.5) 70 (2.0)
(55.3) 1120 (56.8) 1135 (56.8) 1176 (56.7) 1381 (55.2) 1374 (53.0) 1668 (55.5) 1767 (54.9) 1839 (53.3) 1785 (54.3) 1819 (52.1)Gastrointestinal hemorrhage 26 (2.0) 29 (2.1) 47
Others 754 (58.9) 798 (58.3) 1015Total 1280 1368 1837 1972 2000 2074 2500 2591 3008 3220 3453 3288 3494
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144 Y.-C. Chen et al. / Journal of the Chinese Medical Association 76 (2013) 140e145infection, tumor, hemorrhage, and genetic disorders. Second-
ary AI is often related to pituitary lesion per se or hypothal-
amicepituitaryeadrenal axis suppression caused by critical
illness or long-term use of steroid.1 Although worldwide es-
timates of the incidence of secondary AI vary considerably.8,9
growing numbers of primary cause AI patients have been
observed in the Western population between the 1960s and the
1990s.2 In our study covering a span of 13 years, the incidence
of AI of all causes increased from 6.4 to 15.2/105. The
increasing trend would be steeper because cases in the early
years might include patients who had been diagnosed with AI
before 1996. The increase might be attributed to an aging
population, improving diagnostic ability as well as changing
incidences of underlying diseases.
In our study, most patients were between the ages of 60
years and 80 years at their first hospitalization with an AI
diagnosis. Studies in other countries showed the peak age at
diagnosis was in the 4th decade of life in primary AI and the
6th decade in secondary AI.1 Although we could not differ-
entiate between primary and secondary AI in our study, the
increasing trend of AI incidence in Taiwan can probably be
attributed to the growing number of secondary AI cases in that
the elderly population had the most marked increase in the
number of patients and incidence.
In the literature, the type and locality of hospitals in which
AI was treated had seldom been studied. In our study, nearly
90% of AI patients were first diagnosed in academic medical
centers and metropolitan hospitals. The number of AI patients
treated at metropolitan hospitals increased markedly over time
and even exceeded that number treated at academic medical
centers. In the meantime, the number of newly diagnosed AI
patients also markedly increased at hospitals in southern Tai-
wan. These facts might imply that these hospitals have a higher
level of ability to diagnose AI. The lower number of AI patients
at local community hospitals might just reflect the possibility
that critically ill patients are rarely treated there. In our study,
most AI patients were treated in the internal medicine wards.
The reason might be that AI predominantly resulted from
medical illnesses such as autoimmune disorder and infection.
Another reason might be that some patients of AI resulting from
surgical procedures were transferred to the internal medicine
wards during hospitalization. However, the NHI records cannot
provide sufficient clues for the latter situation.
In our study, AI was seldom the sole diagnosis in hospital-
ized patients. Among all comorbidities of AI, the number of
patients with infectious and pulmonary diseases increased
disproportionately in comparison to AI incidences within the
study period. The role of infectious stress in AI has been well-
studied.10e12 A recent study in Germany revealed that infec-
tious diseases can trigger adrenal crises in patients with chronic
AI.13 Some studies also found that a high proportion of patients
with severe community-acquired pneumonia or sepsis had
AI.11,12 The close relationship between adrenal function and
the severity of community-acquired pneumonia has also been
reported in Japan.14 Another major comorbidity, electrolyte
imbalance, is one of the alert signs of AI.15 Although AI is an
uncommon cause of hyponatremia,16 it has been found thathyponatremia may be observed in approximately 80% of acute
adrenal crises.17 In our study, only 4.8% patients with first
diagnosed AI had electrolyte imbalance. This comparatively
low percentage might suggest that the severity of AI of most
hospitalized patients in Taiwan does not reach the crisis level.
Furthermore, a recent study disclosed that concomitant dia-
betes mellitus might increase the frequency of adrenal crises
among patients with chronic AI.18 In our study, diabetes mel-
litus and other endocrine diseases do not seem to have rela-
tionship with the increase of AI incidence.
There were some limitations in our study. Only the datasets
of hospitalizations were available for analysis. The incidence
might have been underestimated because those unrecognized
or treated only in an ambulatory setting were not included in
our study. We could not differentiate the primary and secondary
causes of AI because they share the same coding in ICD-9-CM.
Moreover, our datasets did not provide any laboratory results or
drug prescriptions so that the severity of AI could not be
known. Similarly, because the extent of prior patient medi-
cation before admission was unknown, we could not clarify the
influence of therapeutic glucocorticoid administration on the
development of AI. Finally, because any attempt to link
the patients within the NHIRD to their original medical records
is not permitted, the cause-and-effect relationships between AI
and comorbidities could not be ascertained.
In conclusion, the annual incidence of AI in Taiwan had
continuously increased in recent years, and elderly patients
accounted for the majority of the increase. In the face of an
aging population, Taiwanese physicians should become more
aware of the clinical signs and symptoms of AI, thereby giving
this easily overlooked and increasingly prevalent disease the
attention it deserves.
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